XSHE
002312
Market cap2.30bUSD
Oct 09, Last price
8.27CNY
1D
1.35%
1Q
0.98%
Jan 2017
-5.49%
IPO
163.38%
Name
Sichuan Development Lomon Co Ltd
Chart & performance
P/E
37.71
P/S
1.57
EPS
0.22
Div yield, %
1.73%
Shrs. gr., 5y
1.84%
Rev. gr., 5y
8.41%
Revenues
9.96b
+21.74%
Net income
414m
-22.31%
CFO
515m
-29.73%
Dividend
Oct 14, 20260.05 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sichuan Development Lomon Co., Ltd. is a Chinese enterprise primarily engaged in offering outsourced financial solutions. The company assists the banking sector by streamlining operational procedures, implementing centralized platform governance, and providing data-driven analytics and services based on big data. Furthermore, it manufactures a range of phosphorus-based chemical products, including industrial-grade monoammonium phosphate, calcium hydrogen phosphate for animal feed, and fertilizer-grade monoammonium phosphate. Established in 1997, the firm, initially named Chengdu Santai Holding Group Co., Ltd., is headquartered in Chengdu, China.
Key people
Quanfang Zhu
Chairman of the Board · since 2024
Guanghui Zhu
Chief Financial Officer · since 2021
Jun Chen
Executive Vice President · since 2024
Bosong Deng
Vice President · since 2024
Xian Lu
Vice President · since 2023
Xianming Luo
Vice President · since 2021
Feng Duan
Chief Safety Officer · since 2022
Feng He
Chief Engineering · since 2024
Min Huang
Director · since 2024
Huamei Song
Secretary of the Board, Staff Elected Director · since 2024
Xu Zhang
Director · since 2024
Bing Zhou
Director · since 2024
Independent Director · since 2024
Xuesong Tang
Independent Director · since 2024
Huailing Zhang
Independent Director · since 2024
Headquarters & legal address
成都市金牛区高科技产业园区蜀西路42号
成都市, SC 100000
CN
成都市, SC 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||